| Developers: | EchoNous |
| Date of the premiere of the system: | September 2020 |
| Branches: | Pharmaceuticals, medicine, healthcare |
Content |
2021: Start Selling
In a case study conducted from April 2020 to February 2021, researchers used the Kosmos system to scan more than 1,200 patients and concluded that it yields comparable results with more expensive mobile ultrasound systems on the cart. The company said that by the beginning of July 2021 the device is already being sold and costs less than $10 000.
In early July 2021, EchoNous announced the raising of $60 million to support the commercial launch of a portable device for ultrasound, ECG and stethoscopy based on Kosmos AI. Kennedy Lewis Investment invested in the EchoNous. Prior to this, the main investor in the EchoNous was the KKR fund, which invested $35 million in developers in 2015 and 2017.
EchoNous said that the proceeds will help advance the commercial launch of an ultrasound system controlled by Kosmos artificial intelligence, designed to obtain diagnostic-quality images along with larger, less portable and more expensive imaging devices.
EchoNous CEO Kevin Goodwynbrook drew attention to the fact that the attracted investments mark a turn to an exciting future for Kosmos, while medicine will rely on highly efficient ultrasound technologies that are easy to implement and cost-effective.
 | EchoNous has an exceptional track record in the development of high-quality ultrasonic devices with artificial intelligence that are more intelligent, affordable and easy to use. Kosmos' superior image quality, mobility and accessibility can significantly improve patient care and reduce healthcare costs, "said Rich Humer, managing director and head of investment in biological sciences at Kennedy Lewis. |  |
2020: Announcement of Kosmos - portable device for ultrasound, ECG and stethoscopy
At the end of September 2020, EchoNous launched a 3-in-1 portable device called Kosmos for ultrasound, ECG and stethoscopy. Thanks to AI technologies, Kosmos can improve the quality of data and the accuracy of its interpretation both individually and in combination, the manufacturer claims.
During the study, Kosmos automatically marks scanned structures in real time, for example, by determining the size of the right and left atrium and ventricles of the heart. In addition, the device automatically calculates important physiological indicators, such as ejection fraction or impact volume. Kosmos also records heart rates, and in the future, according to the developers, will be able to interpret ECG and heart auscultation indicators.
During ultrasound scanning, Kosmos gives the user the necessary instructions, for example, "rotate the sensor clockwise," which are displayed in real time on the screen. This allows even a novice ultrasound specialist to quickly learn how to obtain high-quality images. Kosmos also automatically evaluates the quality of the resulting image in real time on a scale of 1 to 5. Thanks to this, the clinician can be trained using immediate feedback, and in addition, receives a standard of image quality that can be guided in the future.
The developers believe Kosmos will help doctors and researchers study pathological processes and improve patient care. AI training and testing on large datasets improves diagnostic accuracy when interpreting individual or combined signals. At the same time, conducting three studies at once with interpretation of the results allows clinicians to devote more time to communicating with the patient and solving his problems.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |